This conversation discusses the use of narrowband UVB (NB-UVB) light therapy to treat multiple sclerosis (MS), particularly MS fatigue. The therapy, already FDA-cleared for dermatological conditions, shows promise in clinical trials for reducing MS inflammation and fatigue.
The talk highlights research indicating a strong correlation between sunlight exposure and better MS outcomes, suggesting NB-UVB as a beneficial "sun surrogate." Current limitations to adoption for MS include its lack of neurological coverage. Its present indication is for dermatological conditions - even though positive results from dermatology suggest potential for broader adoption. The anticipated FDA approval for pediatric MS later this year is discussed. The discussion also features a patient testimonial from Kathy Reagan Young, MS patient,and MS patient advocate, emphasizing the positive impact of NB-UVB in her own experience.
Resources mentioned in this episode:
· Website: https://www.cytokind.net/
· References: https://www.cytokind.net/resources/
· Kathy’s weekly newsletter: https://www.FUMSnow.com/6pack/
· Kathy’s website: https://fumsnow.com/
Your Next Steps:
→ Free 5-Day MS Strength Camp: https://bit.ly/2RraBYx
→ Free Weekly Newsletter: https://bit.ly/3kcyjH8
More Free Videos:
★Foot Drop Workout: https://bit.ly/420fNWo
★ Hip Flexor Workout: https://bit.ly/420fNWo
★ Improve Mobility Workout: https://bit.ly/420fNWo
Ready to upgrade to our Membership Club?
→ Learn about the MS Workouts steadypace™ club: https://bit.ly/3BIJr7P
For additional information and resources, please visit https://www.msworkouts.com
These videos do not provide medical advice and are for informational/educational purposes only. The videos are not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen in any of our videos.